Trial intelligence / Profile preview

DBS versus venous sampling for tacrolimus therapeutic drug monitoring after kidney transplantation

NL-OMON43269Active, not recruiting

Start
Oct 2016
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of tacrolimus in kidney transplant (2 arms), sponsored by None. Primary endpoint: Average number of scheduled outpatient clinic visits. Started Oct 2016; status: active, not recruiting.

02

Drugs

tacrolimus
03

Conditions

kidney transplant

Beyond the preview

Go deeper on NL-OMON43269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call